文献速递白血病淋巴瘤

起始阶段的终结:单细胞测序在慢性淋巴细胞白血病中的应用

The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia.
PubMed 文献 · Blood · 2023-01-01

单细胞分析技术已从少数细胞发展到可同时处理数十万个细胞,可进行遗传、转录、表观遗传和空间分析及多组学整合。慢性淋巴细胞白血病(CLL)因循环血液中可获得纯白血病细胞和免疫细胞而处于基因组研究前沿。本文综述单细胞分析在CLL中的应用,揭示疾病自然进展、新疗法影响及与共生非恶性免疫细胞的相互作用。

要点

  • 单细胞分析已可对数十万个细胞进行遗传、转录、表观遗传和空间分析及多组学整合。
  • CLL因循环血液中易获得纯白血病细胞和免疫细胞而处于基因组研究前沿。
  • 单细胞分析在CLL中揭示疾病自然进展、新疗法影响及与共生非恶性免疫细胞的相互作用。

核心结论

  • 单细胞分析技术革命尚处起始阶段终结之时,CLL有望从中获益,既可揭示新的基础生物学知识,也可为制定个体化诊断、治疗和监测方案提供路径。

研究设计与样本

  • 本文为综述,回顾单细胞分析在慢性淋巴细胞白血病(CLL)中的近期应用。

主要发现

  • 单细胞分析已揭示对CLL自然进展、新疗法影响及与共生非恶性免疫细胞相互作用的新认识。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Single-cell analysis has emerged over the past decade as a transformative technology informative for the systematic analysis of complex cell populations such as in cancers and the tumor immune microenvironment. The methodologic and analytical advancements in this realm have evolved rapidly, scaling from but a few cells at its outset to the current capabilities of processing and analyzing hundreds of thousands of individual cells at a time. The types of profiling attainable at individual cell resolution now range from genetic and transcriptomic characterization and extend to epigenomic and spatial analysis. Additionally, the increasing ability to achieve multiomic integration of these data layers now yields ever richer insights into diverse molecular disease subtypes and the patterns of cellular circuitry on a per-cancer basis. Over the years, chronic lymphocytic leukemia (CLL) consistently has been at the forefront of genomic investigation, given the ready accessibility of pure leukemia cells and immune cells from circulating blood of patients with this disease. Herein, we review the recent forays into the application of single-cell analysis to CLL, which are already revealing a new understanding of the natural progression of CLL, the impact of novel therapies, and the interactions with coevolving nonmalignant immune cell populations. As we emerge from the end of the beginning of this technologic revolution, CLL stands poised to reap the benefits of single-cell analysis from the standpoints of uncovering fresh fundamental biological knowledge and of providing a path to devising regimens of personalized diagnosis, treatment, and monitoring.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Nagler A, Wu CJ. The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia. Blood. 2023. PMID: 36095842. doi:10.1182/blood.2021014669

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。